LMB-1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LMB-1, covering 2008-03-04 to 2008-03-04. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab [Phase 2]